HCM
IDXX icon

HMS Capital Management’s Idexx Laboratories IDXX Stock Holding History

HMS Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-70
Closed -$19K – 253
2019
Q2 		$19K Buy
+70
New +$17.2K 0.01% 247
2018
Q4 		– Sell
-822
Closed -$205K – 199
2018
Q3 		$205K Buy
+822
New +$200K 0.1% 171

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

HMS Capital Management's IDXX Position: Q3 2019 in Review

HMS Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2019, closing a stake of 70 shares — an estimated $19K sold.

HMS Capital Management first reported a position in IDXX in Q3 2018 and held it in 2 quarters. The position peaked at $205K in Q3 2018. 719 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

  • HMS Capital Management reported no remaining Idexx Laboratories position as of Q3 2019 after selling out during the quarter.
  • HMS Capital Management sold 70 Idexx Laboratories shares in Q3 2019, an estimated $19K.
  • HMS Capital Management first reported a position in Idexx Laboratories in Q3 2018 and held it in 2 quarters.
  • HMS Capital Management's Idexx Laboratories position peaked at $205K in Q3 2018.
  • 719 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on HMS Capital Management's 13F filing for Q3 2019, filed 15 Oct 2019.